O. Christensen
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
Papers in
- Oncology 15
- Colorectal Cancer Treatments and Studies 6
- Cancer Treatment and Pharmacology 6
-
- Angiogenesis and VEGF in Cancer 7
- PI3K/AKT/mTOR signaling in cancer 3
- Co-authors
- Erik Christensen (1 shared paper)Dirk Strumberg (10 shared papers)Heike Richly (4 shared papers)K. Mross (5 shared papers)E. Brendel (6 shared papers)M. E. Scheulen (6 shared papers)Beate Schultheis (3 shared papers)Brian Schwartz (4 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)European Journal of Cancer (4 papers)Annals of Oncology (3 papers)British Journal of Cancer (2 papers)FEBS Letters (1 paper)
- Partner nations
- GermanyUnited StatesDenmark
In The Last Decade
O. Christensen
29 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 91
- Hepatology 170
- Oncology 484
- Pathology and Forensic Medicine 170
- Pulmonary and Respiratory Medicine 286
- Gastroenterology 48
Countries citing papers authored by O. Christensen
This map shows the geographic impact of O. Christensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Christensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Christensen more than expected).
Fields of papers citing papers by O. Christensen
This network shows the impact of papers produced by O. Christensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Christensen. The network helps show where O. Christensen may publish in the future.
Co-authors
The 25 scholars most cited alongside O. Christensen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 204 | |
| 2 | 1988 | 121 | |
| 3 | 2006 | 119 | |
| 4 | 2006 | 115 | |
| 5 | 2006 | 87 | |
| 6 | 2008 | 68 | |
| 7 | 2004 | 44 | |
| 8 | 1999 | 42 | |
| 9 | 2012 | 40 | |
| 10 | 2000 | 36 | |
| 11 | 2010 | 25 | |
| 12 | 2010 | 20 | |
| 13 | 2011 | 16 | |
| 14 | 2008 | 16 | |
| 15 | 2008 | 14 | |
| 16 | 2005 | 12 | |
| 17 | 2009 | 12 | |
| 18 | 1976 | 10 | |
| 19 | [Adverse effects of selective serotonin uptake inhibitors. Hyponatremia caused by Schwartz-Bartter syndrome]. | 1996 | 10 |
| 20 | 2006 | 10 |
About O. Christensen
O. Christensen is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Hepatology and Cancer Research, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Cancer Treatment and Pharmacology (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer Research and Treatments (3 papers), Renal cell carcinoma treatment (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Hepatology (170 citations), Oncology (484 citations), Pathology and Forensic Medicine (170 citations), Pulmonary and Respiratory Medicine (286 citations) and Gastroenterology (48 citations). O. Christensen has collaborated with scholars based in Germany, United States and Denmark. Frequent co-authors include Erik Christensen, Dirk Strumberg, Heike Richly, K. Mross, E. Brendel, M. E. Scheulen, Beate Schultheis, Brian Schwartz, Annette Frost and Martin Büchert. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, British Journal of Cancer and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.